ADIPOQ and type 2 diabetes mellitus: The combination of adiponectin with IL-1Ra achieved an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.90 (95% confidence interval (CI): 0.83-0.97) in distinguishing T3cDM (PDAC- and CP-related) from T2DM, with an optimal sensitivity of 83.7% (CI: 68.0-93.8%) and specificity of 90.0% (CI: 73.5-97.9%) (Figure 4c).